We further show that targeted knockdown of fibulin-3 or inhibition of this protein with a novel humanized fibulin-3–targeting antibody reduces the immunosuppressed status of TAMs and increases macrophage cytotoxicity against GBM cells. The gene discussed is EFEMP1; the disease is glioblastoma.